BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 66 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,081,343 | -17.8% | 1,948,740 | -6.4% | 0.01% | -16.7% |
Q2 2023 | $34,169,806 | -6.2% | 2,080,987 | -4.6% | 0.01% | -7.7% |
Q1 2023 | $36,440,232 | +11.1% | 2,180,744 | +2.6% | 0.01% | +8.3% |
Q4 2022 | $32,808,840 | -23.6% | 2,126,302 | -26.1% | 0.01% | -36.8% |
Q3 2022 | $42,954,000 | -19.9% | 2,877,019 | -11.9% | 0.02% | -13.6% |
Q2 2022 | $53,642,000 | -29.0% | 3,264,909 | -13.3% | 0.02% | -12.0% |
Q1 2022 | $75,518,000 | -26.8% | 3,764,598 | -7.5% | 0.02% | -16.7% |
Q4 2021 | $103,179,000 | -23.8% | 4,068,605 | -18.9% | 0.03% | -30.2% |
Q3 2021 | $135,366,000 | -1.0% | 5,017,287 | +6.1% | 0.04% | -2.3% |
Q2 2021 | $136,772,000 | +27.1% | 4,729,323 | +15.6% | 0.04% | +22.2% |
Q1 2021 | $107,619,000 | +65.7% | 4,091,979 | +80.5% | 0.04% | +63.6% |
Q4 2020 | $64,943,000 | +41.6% | 2,266,776 | +17.9% | 0.02% | +29.4% |
Q3 2020 | $45,856,000 | +49.3% | 1,922,681 | +30.9% | 0.02% | +30.8% |
Q2 2020 | $30,714,000 | +97.1% | 1,468,888 | +68.7% | 0.01% | +85.7% |
Q1 2020 | $15,584,000 | – | 870,605 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |